# FDA Inspection 1241625 - General Hospital Corporation (The) - May 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/d82f1bfe-d438-49ce-8b8e-7a64876afba3
Source feed: FDA_Inspections

> FDA Inspection 1241625 for General Hospital Corporation (The) on May 23, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241625
- Company Name: General Hospital Corporation (The)
- Inspection Date: 2024-05-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1241625 - 2024-05-23](https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/e738af6e-d8d5-413b-8b09-d618e307f7df)
- [FDA Inspection 1110333 - 2019-10-23](https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/9f318d27-ba03-4d0a-8b9d-8b0b9978d929)
- [FDA Inspection 992257 - 2016-10-20](https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/541ecc6a-226f-45ea-83a4-06f4f00fdb2c)
- [FDA Inspection 876646 - 2014-04-28](https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/44f4a242-0dbf-409c-8ada-e29ccebbbe2c)
- [FDA Inspection 743401 - 2011-08-12](https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/6ffe281e-40f3-4965-ade4-d633b212a197)

Company: https://www.keypedia.com/companies/general-hospital-corporation-the/469c1e4a-068e-47c6-82e0-601bd44c6c57

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d